Literature DB >> 8403668

Gentamicin-impregnated polymethylmethacrylate beads compared with systemic antibiotic therapy in the treatment of chronic osteomyelitis.

R P Evans1, C L Nelson.   

Abstract

A model of chronic osteomyelitis was used to evaluate the efficacy of treatment with debridement alone; debridement plus gentamicin-polymethylmethacrylate (PMMA) bead implantation; debridement plus systemic antibiotic therapy; and debridement plus systemic antibiotics and bead implantation. Debridement with the implantation of gentamicin-PMMA beads and debridement followed by systemic antibiotics were significantly more successful forms of treatment for chronic osteomyelitis than debridement alone or debridement with the implantation of PMMA beads not impregnated with antibiotics. Debridement followed by the implantation of PMMA-gentamicin beads and the use of systemic antibiotics produced the greatest success rate. Treatment with a combination of gentamicin-PMMA beads and systemic antibiotics resulted in a 100% success rate, which, although not statistically better than either treatment alone, suggests a trend.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403668

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  Comparison of various surgical methods in the treatment of implant-related infection.

Authors:  Muhittin Sener; Cemal Kazimoglu; Hasan Karapinar; Izge Günal; Ilhan Afşar; Asli Gamze Karataş Sener
Journal:  Int Orthop       Date:  2009-03-19       Impact factor: 3.075

Review 2.  Antibiotic-impregnated cement and beads for orthopedic infections.

Authors:  D A Wininger; R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 3.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

4.  Cierny-Mader Type III chronic osteomyelitis: the results of patients treated with debridement, irrigation, vancomycin beads and systemic antibiotics.

Authors:  Hakan Kinik; Mert Karaduman
Journal:  Int Orthop       Date:  2007-03-21       Impact factor: 3.075

Review 5.  Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis.

Authors:  Caleb A Ford; James E Cassat
Journal:  Expert Rev Anti Infect Ther       Date:  2017-09-01       Impact factor: 5.091

6.  [Musculoskeletal infections in the era of multiresistant pathogens].

Authors:  T Grünewald; B R Ruf
Journal:  Unfallchirurg       Date:  2012-06       Impact factor: 1.000

7.  Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin.

Authors:  Yaron S Brin; Jacob Golenser; Boaz Mizrahi; Guy Maoz; Abraham J Domb; Shyamal Peddada; Shmuel Tuvia; Abraham Nyska; Meir Nyska
Journal:  J Control Release       Date:  2008-07-20       Impact factor: 9.776

8.  [MRSA-infections-treatment with intraoperatively produced gentamycin-vancomycin PMMA beads].

Authors:  J Kelm; K Anagnostakos; T Regitz; E Schmitt; G Schneider; F Ahlhelm
Journal:  Chirurg       Date:  2004-10       Impact factor: 0.955

9.  Mechanical properties and elution characteristics of polymethylmethacrylate bone cement impregnated with antibiotics for various surface area and volume constructs.

Authors:  Richard E Duey; Alexander C M Chong; David A McQueen; James L Womack; Zheng Song; Tristan A Steinberger; Paul H Wooley
Journal:  Iowa Orthop J       Date:  2012

10.  In vivo evaluation of temperature-responsive antimicrobial-loaded PNIPAAm hydrogels for prevention of surgical site infection.

Authors:  John M Heffernan; Derek J Overstreet; Brent L Vernon; Ryan Y McLemore; Tamas Nagy; Rex C Moore; Vajra S Badha; Erin P Childers; Michael B Nguyen; Daniel D Gentry; Francis M Calara; W Brian Saunders; Tim Feltis; Alex C McLaren
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2021-06-15       Impact factor: 3.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.